What is Wegovy (Semaglutide) for Weight Loss? 

Wegovy (Semaglutide) is a recently FDA-approved weekly injectable drug for weight loss management for adults. Ozempic (Semaglutide) is the same weekly injectable medicine as Wegovy (Semaglutide). Ozempic has FDA-approval for the treatment of Type 2 Diabetes. However, Ozempic is often prescribed off-label for medical weight loss. La Chelè Medical offers Wegovy (Semaglutide) in New Hope and Newtown PA. 

Those with diabetes taking Semaglutide (Ozempic) experienced very potent weight loss effects.  Novo-Nordisk, the manufacturer of Semaglutide, increased the dose and started marketing it as a weight loss management drug under the name of Wegovy.   

How does Wegovy (Semaglutide) work? 

Wegovy mimics the effects of a hormone called Glucagon Like Peptide 1 or GLP-1. Wegovy needs to be injected under the skin 1 time a week for weight loss management. Patients will be taught to administer these injections at home.

Who can use Wegovy? 

Wegovy is a weekly injectable treatment prescribed by our La Chelè Board-Certified Endocrinologist, Dr. Saltzman. Wegovy can be prescribed for weight loss management in patients with a BMI at or above 27. Wegovy is self-administered once a week and is another FDA-Approved option for Weight Loss Management.  Wegovy is best used for patients who struggle to control their food and snacking intake.  Combining Wegovy with the La Chelè Diet plans and a healthy lifestyle should help patients to lose and keep a significant amount of weight off long-term..   

The custom La Chelè dietary plan will work well with Wegovy injections.  On The La Chelè Diet Plan, you will receive instruction on how to incorporate a wide variety of macronutrients, like protein, fats, carbohydrates and vitamins and minerals into your diet.  The correct ratio of these Macronutrients are necessary for correct fat metabolism in order to burn stubborn body fat. 

Wegovy (Semaglutide) Side Effects 

The most common side effects recorded in the clinical trials are nausea, vomiting, and diarrhea.  These side effects are common with the use of GLP-1, like Ozempic.  Wegovy is a stronger version of Ozempic and may create similar side effects.  95% of patients using Wegovy continued the trial and completed the study.  Less common potential side effects include kidney damage (related to dehydration), gallstones and pancreatitis. Although studies have shown an increase in Medullary Thyroid Cancer in rodents, there have NOT been any cases of Medullary Thyroid Cancer in humans related to Wegovy (or other GLP-1 drugs).  


3 things to consider when you try Wegovy 

  1. If you have tried other GLP-1medications like Saxenda or Ozempic in the past and did not have success, you may require a higher dose or a different weight-loss medication. 
  2. It is common for patients to experience stalled weight loss and rebound weight gain upon the discontinuation of Wegovy or if he or she returns to unhealthy eating habits.  Developing good eating habits and utilizing the La Chele Diet Plan will help minimize the opportunity for rebound weight gain.  
  3. Wegovy can be pricey if paid entirely out of pocket with a price tag of $1,000 to $1,500 per month.  Make sure you consider the cost when signing up for this treatment and check to see if it is covered by your insurance. 


Where can I Buy  Wegovy (Semaglutide)? 

You may schedule a consultation with Dr. Saltzman in one of our locations to see if Wegovy, is right for you. 

What is the cost of Wegovy for weight loss? 

When paid for out of pocket, Wegovy  costs around $1,000 to $1,500 per month 

 When used under the care of our Medical Team at La Chelè, Wegovy is an effective and highly coveted weight loss management medication. Call La Chelè Medical Aesthetics today to see if Wegovy is right for you. 

La Chele Medical is proudly serving New Hope, Newtown, Yardley, Langhorne, Princeton, Horsham, Upper Dublin, Princeton, Upper Makefield, Fairless Hills, Richboro, Northampton, Wrightstown, Warminster, and other surrounding areas in the Bucks County Region.